Ashley L. is a seasoned leader in Quality Assurance and Regulatory within the biotechnology and healthcare sectors, boasting over ten years of expertise in transforming drug product quality. Currently serving as the Sr. Director of Quality for Gene Therapy at Beam Therapeutics, Ashley L. drives strategic development and implementation of GxP quality operations. Previously, they have held pivotal roles in esteemed organizations such as Cartesian Therapeutics, MFG One LLC, and Children's National Medical Center, where they championed significant improvements in quality metrics, compliance, and operational efficiencies. Ashley L. established a boutique consulting firm, BioGenesis Consulting Inc., and has also contributed to regulatory oversight at the FDA, specializing in hematology and oncology therapeutics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices